Global Shrimp Disease Diagnostics Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Global Shrimp Disease Diagnostics Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Shrimp disease diagnostics refer to the process of identifying and detecting diseases that affect shrimps in aquaculture. It involves the use of various diagnostic techniques, including molecular biology, histopathology, immunology, and microbiology, to detect and diagnose diseases accurately. These diagnostic tools help shrimp farmers monitor the health status of their shrimp populations, identify potential disease outbreaks, and implement timely interventions to prevent the spread of diseases.

Market Overview:

The latest research study on the global Shrimp Disease Diagnostics market finds that the global Shrimp Disease Diagnostics market reached a value of USD 181.79 million in 2023. It’s expected that the market will achieve USD 313.9 million by 2029, exhibiting a CAGR of 9.53% during the forecast period.

Increased demand for shrimp

Shrimp is a common seafood. The meat is very soft and easy to digest. Shrimp is rich in protein, magnesium, calcium, vitamin D and other nutrients, which can improve the body's immune resistance, so it is very suitable for people who are weak and need to take care of themselves after illness. Additionally, shrimp contains an antioxidant called astaxanthin, which helps prevent wrinkles and reduce sun damage. Global demand for shrimp is rising as consumers' disposable incomes rise and more people become aware of the health benefits of eating them. As consumer demand for shrimp continues to grow, the scale of shrimp farming continues to expand. Bacterial and viral infections are major threats to shrimp production industries in various countries. Shrimp farming in many countries faces economic losses due to different diseases. The application of shrimp disease diagnostics will help maintain the biosecurity, food safety and quality of shrimp farming and the sustainability of shrimp farming. Therefore, as consumer demand for shrimp increases and shrimp farming continues to expand, so does the demand for shrimp disease diagnostic systems.

Region Overview:

In 2022, the share of the Shrimp Disease Diagnostics market in North America stood at 4.39%.

Company Overview:

Thermo Fisher Scientific is one of the major players operating in the Shrimp Disease Diagnostics market, holding a share of 21.94% in 2023.

Segmentation Overview:

Among different product types, WSSV (White Spot Syndrome Virus) segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Fisheries segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Shrimp Disease Diagnostics market covered in Chapter 3:

BiOptic Inc
Speedy Assay Sd​​n Bhd
SHANSHIBIO
Thermo Fisher Scientific
AquaSol, Inc. 
Nusantics
GeneReach Biotechnology Corp.
Lab - Ind Resource Sdn Bhd.
HiMedia Laboratories
SUREBIO
Auro Biotechnologies
Genics

In Chapter 4 and Chapter 14.2, on the basis of types, the Shrimp Disease Diagnostics market from 2019 to 2030 is primarily split into:

WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
EMS (Early Mortality Syndrome)
EHP (Enterocytozoon hepatopenaei)
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Shrimp Disease Diagnostics market from 2019 to 2030 covers:

Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)